← All companies

AARD

Aardvark Therapeutics, Inc.

AARD Nasdaq Pharmaceutical Preparations EDGAR ↗

$7.08

+0.68 +10.63%

Key statistics

from XBRL data in SEC filings

Market cap

$154M

Revenue (TTM)

$0.00

Net income (TTM)

-$69.9M

EPS (TTM)

$-3.21

P/E ratio

—

Dividend yield

—

Free cash flow

-$54.3M

Cash

$62.4M

Total assets

$98.6M

Gross margin

—

52-week range

$3.35 – $17.94

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jun 12, 2026 8-K Other events May 14, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Entered a material agreement Mar 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Results of operations (earnings release) Mar 23, 2026 8-K Other events Feb 27, 2026 8-K Director or officer change; Other events Feb 12, 2026 8-K Other events Feb 10, 2026 8-K Other events Jan 12, 2026 8-K Other events Dec 10, 2025 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Other events Nov 6, 2025 8-K Regulation FD disclosure; Other events Nov 4, 2025 8-K Other events Oct 9, 2025 8-K Other events Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Results of operations (earnings release) Aug 13, 2025 8-K Other events Aug 12, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K Amended charter or bylaws; Other events Feb 14, 2025

Other filings

ARS Jul 10, 2026 DEF 14A Jul 10, 2026 PRE 14A Jun 29, 2026 EFFECT Apr 3, 2026 424B5 Apr 3, 2026 CORRESP Mar 30, 2026 UPLOAD Mar 25, 2026 S-8 Mar 24, 2026 S-3 Mar 23, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Feb 11, 2026 4 Dec 12, 2025 4 Dec 12, 2025